Latitude™ is a tissue-free, blood-based, residual disease test (MRD) that delivers fast and reliable results without the need for tumor tissue. It is built on Natera’s MRD expertise and offers high oncordance with Signatera™ in comparative analysis, built using a targeted panel composed of differentially methylated regions specifically for colorectal cancer (CRC).